• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number TFGT-23A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Sepsis (2067); Heart Failure/Congestive Heart Failure (4446)
Event Date 09/09/2023
Event Type  Death  
Event Description
The article, "new challenges for the surgeon in the modern era of transcatheter aortic valves: early single center experience of their surgical explantation", was reviewed.The article presented a case study of a 66-year-old male with prior transcatheter valve replacement and prior prosthetic endocarditis with aortomitral abscess.It was reported that on an unknown date, a 23mm trifecta valve was chosen for aortic valve implant along with a concomitant 29mm edwards perimount valve for mitral valve.It was reported 41 days post-procedure, the patient passed away in the referral hospital due to sepsis with subsequent multiple organ failure.The article concluded long-term durability of transcatheter heart prostheses compared to their surgically implanted counterparts has not been yet established.As long as their different failure modes are not entirely clarified, further long-term clinical and echocardiographic follow-up are required.Initial experience shows that a failing tavi-implant may be conventionally surgically replaced without an excessive operative risk.[the primary and corresponding author was kyriakos spiliopoulos, department of thoracic and cardiovascular surgery, university of (b)(6) greece, with corresponding email: (b)(6)].
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Literature attachment: article title: new challenges for the surgeon in the modern era of transcatheter aortic valves: early single center experience of their surgical explantation.
 
Manufacturer Narrative
As reported in a research article, new challenges for the surgeon in the modern era of transcatheter aortic valves: early single center experience of their surgical explantation.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.From medical review: the cause of death is related to the endocarditis and on-going infection progressing to sepsis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿ GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17878305
MDR Text Key325011290
Report Number2135147-2023-04340
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067018229
UDI-Public05415067018229
Combination Product (y/n)N
Reporter Country CodeGR
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberTFGT-23A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/13/2023
Initial Date FDA Received10/05/2023
Supplement Dates Manufacturer Received11/07/2023
Supplement Dates FDA Received11/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age66 YR
Patient SexMale
-
-